Skip to menu Skip to content Skip to footer

2026

Conference Publication

LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?

Reed, Amy McCart, Kalinowski, Lauren, Maklouf, Shorouk, Djerroudi, Lounes, McLaren, Alexandra, Beecher, Kate, Lal, Samir, Kutasovic, Jamie, Srihari, Sriganesh, Feng, Yufan, Ferguson, Kaltin, Chittoory, Haarika, Sokolova, Anna, Lim, Malcolm, Salomon, Carlos, Porter, Alan, Evans, Elizabeth, Rakha, Emad, Edwards, Joanne, Salomon, Anne, Lakhani, Sunil and Simpson, Peter (2026). LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?. International Invasive Lobular Carcinoma Symposium, San Francisco Ca, Sep 23-25, 2026. NEW YORK: SPRINGER.

LobSig, a prognostic biomarker set for ILC: where are we and why has it taken so long?

2023

Conference Publication

Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newborns

Chand, Kirat, Patel, Jatin, Matthews, Kate, Nano, Rachel, Musco, Hannah, Khosrotehrani, Kiarash, Colditz, Paul and Wixey, Julie (2023). Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newborns. IBRO 11th World Congress of Neuroscience, Granada, Spain, 9-13 September 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.ibneur.2023.08.249

Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newborns